Locations:
Min Investment:
Max Investment:
Target Investment:
2020
2023
2022 - 2023
2020 - 2022
2023
2023
2022
2022
2022
2022
2022
2022
2021
2021 - 2024
2021 - 2024
2005 - 2023
2021 - 2023
2005 - 2021
Responsible for furthering cooperation between Italy and Israel especially in matters related to technology transfer and investment in technology, with a focus on biotechnology, medical devices and healthcare IT
2016 - 2020
2016 - 2020
Metabomed is a drug discovery company in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. Metabomed focuses on targets which are synthetically lethal for biomarker- defined tumors.
2011 - 2016
2011 - 2016
Responsible or the management of the Israel Bioincubator, a strategic initiative designed to stimulate innovation by bridging the gap between academic research and the biotechnology industry in Israel. Acting-CEO for Neviah Genomics, an Israel Bioincubator portfolio company developing biomarkers for drug toxicity Acting CEO for Metabomed, an Israel Bioncubator portfolio company in the space of cancer metabolism Board Director of ChanBio